Nichtentzündliche Erkrankungen des Unterhautbindegewebes

  • S. Marghescu
  • H. Kather
  • B. Simon
  • W. Mohr
Part of the Handbuch der inneren Medizin book series (INNEREN, volume 6 / 2 / C)

Zusammenfassung

Synonyma: Zellulitis, Fibrositis, Pannikulitis, Rheumatismus des subkutanen Fett- und Bindegewebes, Zellulalgie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bassas-Grau E, Bassas-Grau M (1966) Klinische ätiologische, pathologische und therapeutische Überlegungen zur Zellulitis (Pannikulose). Münch Med Wochenschr (span Ausg) 108:431–456.Google Scholar
  2. Braun-Falco O, Scherwitz Ch (1971) Zellulitis. Round-Table-Gespräch anläßlich der Sitzung der Münchener Dermatologischen Gesellschaft am 25. November 1970. Med Klin 66:827–832.Google Scholar
  3. Braun-Falco O, Scherwitz Ch (1972) Zur Histopathologie der sogenannten Cellulitis. Hautarzt 23:71–75.PubMedGoogle Scholar
  4. Dreßler D (1970) Die sogenannte Zellulitis (Pannikulose). Fortschr Med 88:1294–1296.Google Scholar
  5. Ehlers G (1972) Über die sogenannte Pannikulose unter besonderer Berücksichtigung histologischer und histochemischer Untersuchungen. Z Rheumaforsch (Suppl 2) 31:207–214.Google Scholar
  6. Kreysel HW, Kammerer B (1974) Die sog Zellulitis im Brennpunkt moderner Untersuchungsverfahren (Morphologie, Biochemie, Klinik, Therapie und ihre Nebenwirkungen). Med Welt 25:625–635.PubMedGoogle Scholar
  7. Lagèze P 929 Sciatique et infiltrat cellulalgique. Thèse méd Lyon.Google Scholar
  8. Lisch H-J, Sailer S, Sandhofer F, Braunsteiner H (1970) Untersuchungen an isolierten menschlichen Fettzellen verschiedener Fettgewebsregionen. I. Beziehungen zwischen relativem Körpergewicht und Zellvolumen. Klin Wochenschr 48:1349–1353.PubMedCrossRefGoogle Scholar
  9. Marghescu S (1973) Pannikulose — sogenannte Zellulitis. Schmerzhafte regionale Adipositas — keine Krankheit sensu strictiori. Aerztl Prax 25:2346–2348.Google Scholar
  10. Müller G, Nürnberger F (1972) Anatomische Grundlagen der sog. „Cellulitis“. Arch Dermatol Forsch 244:171–172.PubMedCrossRefGoogle Scholar
  11. Nürnberger F, Mende H, Roedel P (1972) Behandlungsergebnisse bei der sog „Cellulitis“ mit Verteilerenzymen im einfachen Blindversuch. Arch Dermatol Forsch 244:173–182.PubMedCrossRefGoogle Scholar
  12. Ulrich W (1976) Zellulitis ist heilbar. Econ, Düsseldorf Wien.Google Scholar
  13. Wilde H (1970) „Zellulitis“? Ein Beitrag zur Körperverformung durch die Mode. Hautarzt 21:379.PubMedGoogle Scholar
  14. Aarseth S (1967) Lipodystrophic diabetes. Diabetologica 3:535.Google Scholar
  15. Bandmann HJ, Romm N, Stehr K (1965) Beitrag zur Klassifizierung der Acanthosis nigricans. Hautarzt 16:492–498.PubMedGoogle Scholar
  16. Barraquer L (1949) Pathogenesis of progressive cephalothoracic lipodystrophy. J Nerv Ment Dis 109:113–121.CrossRefGoogle Scholar
  17. Belenkaia NB (1961) Association of progressive lipodystrophy with nephrotic syndrome. Zdravookhr Beloruss 7:56–60.Google Scholar
  18. Beradinelli W (1954) An undiagnosed endocrinometabolic syndrome. Report of 2 cases. J Clin Endocrinol Metab 14:193–204.CrossRefGoogle Scholar
  19. Berger EH (1932) Progressive lipodystrophy. Med Clin North Am 15:1431–1440.Google Scholar
  20. Boudin G, De Gennes J, Pepin B, Barraine R, Saltiel H (1963) Diabète lipo-atrophique avec manifestations neurologiques. Bull Soc Med Paris 114:895–918.Google Scholar
  21. Brezina Z (1970) Ein Beitrag zur progressiven Lipodystrophie im Kindesalter. Kinderaerztl Prax 38:408–410.PubMedGoogle Scholar
  22. Brown E (1958) Progressive lipodystrophy following infection. Arch Pediatr 75:227–232.PubMedGoogle Scholar
  23. Brubaker M, Levan N, Collip P (1965) Acanthosis nigricans and congenital total lipodystrophy. Arch Dermatol 91:320–325.CrossRefGoogle Scholar
  24. Brunzell J, Shankle S, Bethune J (1968) Congenital generalized lipodystrophy accompanied by angiomatosis. Ann Intern Med 69:501–514.PubMedGoogle Scholar
  25. Buchanan D (1956) A case for diagnoses. Pediatrics 18:1013–1018.PubMedGoogle Scholar
  26. Chalmers T, Kekwick A, Pawan G (1958) On the fat mobilising activity of human urine. Lancet II:866–869.CrossRefGoogle Scholar
  27. Chalmers T, Kekwick A, Pawan G (1960) Fat-mobilising and ketonic activity of urin extracts. Lancet II:6–9.CrossRefGoogle Scholar
  28. Choremis K, Constantinides B, Kattamis C (1965) Congenital type of generalized lipodystrophy. Acta Paediatr Scand 54:175–179.PubMedCrossRefGoogle Scholar
  29. Corbin A, Upton G, Mabry C, Hollingworth D (1974) Diencephalic involvement in generalized lipodystrophy:Rationale and treatment with the neuroleptic agent, pimozide. Acta Endocrinol (Kbh) 77:209–220.Google Scholar
  30. Corner BD (1952) Lipoatrophic diabetes. Arch Dis Child 27:300–301.Google Scholar
  31. Cotellessa G (1953) Considerazioni sulla lipodystrofia progressiva. Rass Int Clin Ter 8:473–479.Google Scholar
  32. Craig JW, Miller M (1960) Lipoatrophic diabetes. In: Williams R (ed) Diabetes. Hoeber, New York, Seite 10.Google Scholar
  33. Davis J, Feiwel M (1957) Lipoatrophi, gigantism and hyperlipemia with xanthomatosis and acanthosis nigricans. Br J Dermatol 68:229–230.Google Scholar
  34. Davis J, Tizard J (1954) Generalized lipodystrophy. Infectious mononucleosis. Mild infantile hemiplegia. Proc R Soc Med 47:128.PubMedGoogle Scholar
  35. Derot M, Rosselin G, Assau R, Tchobroutsky G (1966) Taux plasmatiques de l’insuline et de l’hormone de croissance dans deux cas de diabète lipo-atrophique. Bull Soc Med (Paris) 117:601–605.Google Scholar
  36. Dunnigan M, Cockrane M, Kelly A, Scott JW (1974) Familial lipoatrophic diabetes with dominant transmission. J Med 43:33–48.Google Scholar
  37. Epstein E (1971) Lipodystrophy. In:Fitzpatrick TB, Arndt KA, Clark WA, Eisen AZ, Vanscott EJ, Vaughan JH (eds) Dermatology in general medicine. McGraw Hill, New York, Seite 10–11.Google Scholar
  38. Fontan A, Verger P, Couteau J, Pery M (1956) Hypertrophie musculaire generalisée à début précoce, avec lipodystrophie faciale, hepatomégalie et hypertrophie clitoridienne chez une fille de 11 ans. Arch fr Pediatr 13:276–285.PubMedGoogle Scholar
  39. Fosbrooke A, Segall M (1969) Observations on fat and carbohydrate metabolism in generalized lipodystrophy. Biochem J 112:33–34.Google Scholar
  40. Foss I, Trygstad O (1975) Lipodystrophy produced in mice and rabbits by a fraction prepared from the urin from patients with congenital generalized lipodystrophy. Acta Endocrinol (Kbh) 80:398–416.Google Scholar
  41. Fowler P (1955) Lipodystrophia progressiva and temporary hydronephrosis. Br Med J I:1249–1251.CrossRefGoogle Scholar
  42. Gellis S, Green S, Walker D (1958) Chronic renal disease in children with lipodystrophy. Am J Dis Child 96:605–606.Google Scholar
  43. Gibson R (1957) The occurence of progressive lipodystrophy in mental defectives. Can Med Assoc J 77:217–220.PubMedGoogle Scholar
  44. Gold R, Steinbach H (1967) Lipoatrophic diabetes mellitus. Am J Roentgenol 101:884–896.Google Scholar
  45. Gordon H, Pimstone B, Leary P, Gordon W (1971) Congenital generalized lipodystrophy with abnormal growth hormone hoeostasis. Arch Dermatol 104:551–559.PubMedCrossRefGoogle Scholar
  46. Griffith H, Rossini A (1975) A case of lipoatrophic diabetes. Radiology 114:329–330.Google Scholar
  47. Güell-Gonzalez J (1971) Bone lesions in congenital generalized lipodystrophy. Lancet II:104–105.CrossRefGoogle Scholar
  48. Guihard J, Tessier R, Laniece M, Foucauld J, Sibireff J (1971) Diabète lipoatrophique. Ann Pediatr 18:633–634.Google Scholar
  49. Hamwi G, Kruger A, Eymont M, Scarpelli D, Gwinup G (1966) Lipoatrophic diabetes. Diabetes 15:262–267.PubMedGoogle Scholar
  50. Hamza M, Levy M, Broyer M, Habib R (1970) Deux cas de glomérulonéphrite membranoproliférative avec lipodystrophie partielle de type facio-tronculaire. J Urol Nephrol (Paris) 76:1032–1042.Google Scholar
  51. Hartson W (1933) Lipodystrophia progressiva. Lancet II:1416–1418.CrossRefGoogle Scholar
  52. Irgersheimer W (1948) Progressive lipodystrophy. Am J Dis Child 75:206–213.Google Scholar
  53. Jiminez Diaz C, Rodridez-Minon J, Arrieta F (1962) El sidome de lipodistrophia, esteatosis hepatica y diabetes resistente. Rev Clin Esp 86:9–13.Google Scholar
  54. Jolliff JW, Craig J (1967) Lipoatrophic diabetes and mental illness in three siblings. Diabetes 16:708–714.PubMedGoogle Scholar
  55. Jones E (1956) Progressive lipodystrophy. Br Med J I:313–319.CrossRefGoogle Scholar
  56. Keizer D (1953) Trois observations de lipodystrophie progressive. Arch Fr Pediatr 10:283–286.PubMedGoogle Scholar
  57. Kikkawa R, Hoshi M, Shijeta Y, Izumi K (1972) Lack of ketosis in lipodystrophic diabetes. Diabetes 21:827–830.PubMedGoogle Scholar
  58. Köbberling J, Willms B, Kattermann R, Creutzfeld W (1975) Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipoatrophic diabetes. Humangenetik 29:111–120.PubMedCrossRefGoogle Scholar
  59. Lajeune E, Tourniaire J (1969) Altérations osseuses et diabète lipoatrophique. Lyon Med 222:789–800.Google Scholar
  60. Langsch H, Michaelis D, Fischer U (1969) Ungewöhnliches Krankheitsbild einer Patientin mit insulinresistentem Diabetes melitus und hochgradiger Lipoatrophie. Dtsch Gesundh-Wes 24:14–18.Google Scholar
  61. Lawrence RD (1946) Lipoatrophy and hepatomegaly with diabetes, lipemia and other metabolic disturbances. Lancet I:724–731.CrossRefGoogle Scholar
  62. Lillystone D, West R (1975) Lipodystrophy of limbs associated with insulin resistance. Arch Dis Child 50:337–340.CrossRefGoogle Scholar
  63. Ljunghall S, Fjellström K, Wibell L (1974) Partial lipodystrophy and chronic hypocomplementemic glomerulonephritis. Acta Med Scand 195:493–497.PubMedCrossRefGoogle Scholar
  64. Louis L (1969) Lipoatrophic diabetes:An improved procedure for the isolation and purification of a diabetogenic polypeptide from urine. Metabolism 18:545–555.PubMedCrossRefGoogle Scholar
  65. Louis L, Conn J (1972) Diabetogenic polypeptide from human pituitaries similar to that excreted by proteinuric diabetes patients. Metabolism 21:1–9.PubMedCrossRefGoogle Scholar
  66. Louis L, Conn J, Minick M (1963) Lipoatrophic diabetes. Isolation and characterization of an insulin antagonist from urine. Metabolism 12:867–886.PubMedGoogle Scholar
  67. Mabry C, Hollingworth D (1972) Failure of hypophysectomy in generalized lipodystrophy. J Pediatr 81:990–996.PubMedCrossRefGoogle Scholar
  68. Mabry C, Stahl P (1964) Generalized lipodystrophy. Read before the Soc for Pediatrie Res 34th Annual Meeting, Seattle, Abstract.Google Scholar
  69. Mabry C, Hollingworth D, Upton G, Corbin A (1973) Pituitary-hypothalamic dysfunction in generalized lipodystrophy. J Pediatr 82:625–631.PubMedCrossRefGoogle Scholar
  70. Marcus R (1966) Retinopathie, nephropathie and neuropathie in lipodystrophie diabetes. Diabetes 15:351–356.PubMedGoogle Scholar
  71. Masshoff W, Träger K (1975) Fokale Lipodystrophie im Knochenmark. Dtsch Med Wochenschr 100:84–87.PubMedCrossRefGoogle Scholar
  72. Miller M, Shipley R, Shreeve W, Baker N, Craig J (1955) The metabolism of c-14-glucose in normal and diabetic subjects. Trans Assoc Am Physicians 68:199–204.PubMedGoogle Scholar
  73. Mitchell S (1885) Singular case of abscence of adipose matter in the upper half of the body. Am J Med Sci 90:105–106.CrossRefGoogle Scholar
  74. Murrey I (1952a) Lipodystrophy. Br Med J II:1236–1239.CrossRefGoogle Scholar
  75. Murrey I (1952b) Lipoatrophie diabetes. Glasg Med J 33:473–478.Google Scholar
  76. Naito C, Togawa K (1974) A possible role of circulating lipoprotein triglycerides in the increase in concentration of free fatty acids and insulin resistance in total lipodystrophy. J Clin Endocrinol Metab 39:1030–1037.PubMedCrossRefGoogle Scholar
  77. Neumann R (1902) Experimentelle Beiträge zur Lehre vom täglichen Nahrungsbedarf des Menschen unter besonderer Berücksichtigung der notwendigen Eiweißmenge. Arch Hyg 45:1–87.Google Scholar
  78. Oppermann J (1965) Ein Beitrag zur Pathogenese und Therapie der progressiven Lipodystrophie. Z Kinderheilkd 94:25–39.PubMedCrossRefGoogle Scholar
  79. Oseid S (1973) Studies in generalized lipodystrophy. Acta Endocrinol (Kbh) 72:475–494.Google Scholar
  80. Ozer F, Lichtenstein J, Kwiterovich P, McKusik V (1973) A new genetic variety of lipodystrophy. Clin Res 21:533–535.Google Scholar
  81. Pavel I, Cimpeanu S, Nicolesco M, Bonaparte H, Petrovici G, Stoian N (1963) Le diabète lioatrophique est-il un diabète lipidique? Presse Med 71:1379–1382.Google Scholar
  82. Pieragostonie P, Girotti F, Midulla M (1969) Lipodistrofia e gigantismo in un bambino con tumore endocranio. Minerva Pediatr 21:1836–1839.Google Scholar
  83. Pieron H, Perrimond H, Orsini A (1967) Lipoatrophie generalisée chez un enfant de 3 ans par un tumeur diencéphalique. Arch Fr Pediatr 24:827–832.Google Scholar
  84. Piscatelli R, Vieweg W, Havel R (1970) Partial lipodystrophy metabolic studies in 3 cases. Ann Intern Med 73:936–970.Google Scholar
  85. Poley J, Stickler G (1963) Progressive lipodystrophy. Am J Dis Child 106:356–362.PubMedGoogle Scholar
  86. Rastogi S, Walls J, Elliot R, Ashby D, Hart-Mercer J, Kerr D (1969) Lipodystrophy and glomerulonephritis. IVth Int Congr Nephrol, Abstract.Google Scholar
  87. Reed W, Dexter R, Corley C, Fish C (1965) Congenital lipodystrophie diabetes with acanthosis nigricans. Arch Dermatol 91:326–334.CrossRefGoogle Scholar
  88. Reed W, Ragsdale W, Curtis A, Richards H (1968) Acanthosis nigricans in association with various genodermatosis. Acta Derm Veneorol (Stockh) 48:465–473.Google Scholar
  89. Reichel W, Köbberling J, Fischbach H, Scheler F (1976) Membranoproliferative Glomerulonephritis mit partieller Lipodystrophie. Klin Wochenschr 54:75–84.PubMedCrossRefGoogle Scholar
  90. Ruvalcaba R, Kelley V, Samols E (1965) Lipoatrophic diabetes. Am J Dis Child 109:287–294.PubMedGoogle Scholar
  91. Samaan N, Craig J (1969) Serum insuline and growth hormone in lipoatrophic diabetes. Metabolism 18:460–468.PubMedCrossRefGoogle Scholar
  92. Schäfer I, Steinke J, Yaffe S, Dagenais Y (1960) Elevated serum insuline-like activity in patients with lipodystrophy. Am J Dis Child 100:630.Google Scholar
  93. Schwartz R, Schäfer I, Renold A (1960) Generalized lipodystrophy, hepatic cirrhosis, disturbed carbohydrate metabolism and accelerated growth. Am J Med 28:973–985.PubMedCrossRefGoogle Scholar
  94. Scully R, McNeely B (1975) Weekly clinopathological exercises. N Engl J Med 292:35–41.CrossRefGoogle Scholar
  95. Seip M (1959) Lipodystrophy and gigantism with associated endocrine manifestations. A new diencephalic syndrome? Acta Paediatr Scand 48:555–574.Google Scholar
  96. Seip M (1971) Generalized lipodystrophy. Ergeb Inn Med Kinderheilkd 31:59–95.PubMedGoogle Scholar
  97. Seip M, Trygstad O (1963) Generalized lipodystrophy. Arch Dis Child 38:447–453.PubMedCrossRefGoogle Scholar
  98. Senior B (1961) Lipodystrophic muscular hypertrophy. Arch Dis Child 36:426–431.PubMedCrossRefGoogle Scholar
  99. Senior B (1965) Lipodystrophy. In:Renold A, Cahill G (eds) Handbook of physiology. Washington, Am Physiol Soc, Seite 16.Google Scholar
  100. Senior B, Gellis S (1964) The syndrome of total lipodystrophy and of partial lipodystrophy. Pediatrics 33:593–609.PubMedGoogle Scholar
  101. Senior B, Loridan L (1969) Fat cell function and insulin in a patient with generalized lipodystrophy. J Pediatr 74:972–975.PubMedCrossRefGoogle Scholar
  102. Shayomava N (1954) Lipodystrophy in girl 12 years old. Klin Med (Mosk.) 32:67–70.Google Scholar
  103. Shelley W, Izumi A (1970) Annular atrophy of the ankles. Arch Dermatol 102:326–329.PubMedCrossRefGoogle Scholar
  104. Smith P, Morgans M, Clark C, Lennard J, Jonason T (1975) Lidystrophy, pancreatitis and eosinophilia. Gut 16:230–234.PubMedCrossRefGoogle Scholar
  105. Sövik O, Oseid S (1973) Studies in congenital generalized lipodystrophy. Acta Endocrinol (Kbh.) 72:495–505.Google Scholar
  106. Sövik O, Oseid S (1975) Studies in congenital generalized lipodystrophy. Acta Endocrinol (Kbh.) 79:720–728.Google Scholar
  107. Taylor W, Honeycutt W (Kbh.) Progressive lipodystrophy and lipoatrophic diabetes. Arch Dermatol 84:31-36.Google Scholar
  108. Thomson D, Davison A (1972) Glomerulonephritis in association with progressive lipodystrophy investigated by light, immunofluorescence and electron microscopy. Vth Int Congr Nephrol, Abstract.Google Scholar
  109. Thorbjörn B, Brune A, Hansing B, Kjellmann B (1976) Congenital generalized lipodystrophy. Acta Pathol Microbiol Scand [A] 84:47–54.Google Scholar
  110. Torikai T, Fukuchi S, Sasaki C, Ishigaki J, Isawa K, Suzuki A, Namiki T, Hashimoto N, Hashimoto S (1965) Two sibling cases of lipoatrophic diabetes. Endocrinol Jpn 12:197–208.PubMedCrossRefGoogle Scholar
  111. Tzagournis M, George J, Herrold J (1973) Increased growth hormone in partial and total lipoatrophy. Diabetes 22:388–395.PubMedGoogle Scholar
  112. Upton G, Corbin A (1973) Hypothesis:Hypothalamic dysfunction and lipoatrophic diabetes. Yale J Biol Med 46:314–323.PubMedGoogle Scholar
  113. Upton G, Corbin A, Mabry C (1972) The etiology of lipoatrophic diabetes in hypothalamic hypophysiotropic hormones, physiological and clinical studies. Proceed Confr at Acapulco.Google Scholar
  114. Wesenberg R, Gwinn J, Barnes G (1968) The roentgenographic findings in total lipodystrophy. Am J Roentgenol 103:154–164.Google Scholar
  115. Wilkinson G (1941) Progressive lipodystrophy. South Med Surg 103:315–318.Google Scholar
  116. Witzgall H (1957) Hyperlipämische Lipoatrophic Aerztl Wochenschr 12:1093–1100.Google Scholar
  117. Ziegler LH (1928) Lipodystrophies. A report of seven cases. Brain 51:147–167.CrossRefGoogle Scholar
  118. Zöllner N, Dörfler H, Wolfram G (1975) Lipoatrophischer Diabetes. Münch Med Wochenschr 117:1209–1214.Google Scholar
  119. Cohen HJ, Gibbs RC, Minkins W, Frank SB (1970) Painful piezogenic pedal papules. Arch Dermatol 101:112–114.PubMedCrossRefGoogle Scholar
  120. Plewig G, Braun-Falco O (1973) Piezogene Knötchen. Druckbedingte Fersen-und Handkantenknötchen. Hautarzt 24:114–118.PubMedGoogle Scholar
  121. Schubert E, Schilling E, Metz J (1973) Multiple Fettgewebshernien (sog painful piazogenic pedal papules). Hautarzt 24:111–114.PubMedGoogle Scholar
  122. Shelly WB, Rawnsley HM (1968) Painful feet due to herniation of fat. JAMA 205:308–309.CrossRefGoogle Scholar
  123. Abassy A, Massoud G, Rida A (1958) Hand-Schüller-Christian disease. J Pediatr 53:233–240.CrossRefGoogle Scholar
  124. Abt A, Dennenholz E (1936) Letterer Siwe’s disease. Am J Dis Child 51:499–522.Google Scholar
  125. Althoff H (1953) Zur röntgenologischen Diagnose und Therapie des „eosinophilen Granuloms des Knochens“. Z Kinderheilkd 73:487–499.PubMedCrossRefGoogle Scholar
  126. Althoff H (1967) Leukosen und Reticulosen. In:Opitz H, Schmid F (Hrsg) Handbuch der Kinderheilkunde, Bd VI:Erkrankungen der Stützgewebe. Erkrankungen des Blutes und der blutbildenden Organe. Springer, Berlin Heidelberg New York, S 1055–1115.CrossRefGoogle Scholar
  127. Altmann J, Winkelmann R (1962) Xanthoma disseminatum. Arch Dermatol 86:582–585.CrossRefGoogle Scholar
  128. Avery M, McAfee J, Guild H (1957) The course and prognosis of reticuloendotheliosis. Am J Med 22:636–652.PubMedCrossRefGoogle Scholar
  129. Basket E, Nezelhof C (1970) Recent progress in the knowledge of histiocytosis X. Arch Dis Child 45:150–154.PubMedCrossRefGoogle Scholar
  130. Bass M, Sapin S, Hodes H (1953) Use of cortisone and corticotropine in treatment of reticuloendotheliosis in children. Am J Dis Child 85:393–403.Google Scholar
  131. Batson R, Shapiro J, Christie A, Riley H (1955) Acute nonlipid disseminated reticuloendotheliosis. J Dis Child 90:323–343.Google Scholar
  132. Bayer P, Müller M, Machacek E (1972) Zur Biochemie der Hand-Schüller-Christianschen Erkrankung. Z Klin Chem Klin Biochem 10:127–131.PubMedGoogle Scholar
  133. Begemann H, Kaboth W (1974) Die Letterer-Christiansche Krankheit. In:Begemann H (Hrsg) Handbuch der inneren Medizin, 5. Aufl Bd II/5:Krankheiten des lymphocytären Systems. Springer, Berlin Heidelberg New York, S 213–227.Google Scholar
  134. Belart CH (1972) Über einen Fall von Hand-Schüller-Christianscher Erkrankung mit speziellem Befall des Retroperitoneums und dem Bilde der Osmondschen Krankheit. Schweiz Med Wochenschr 102:1091–1095.PubMedGoogle Scholar
  135. Biermann H, Lanman J, Dod K, Kelley K, Miller E, Shimkin M (1952) The ameliorative effect of antibiotics on nonlioid reticuloendotheliosis in identical twins. J Pediatr 40:269–284.CrossRefGoogle Scholar
  136. Birbeck M, Breathnach A, Everall J (1961) An electronmicroscope study of basal melanocyts and high-level clear cells in vitiligo. J. Invest Dermatol 37:51–54.Google Scholar
  137. Brandt M, Langhans P, Clemens M, Heger R (1976) Das eosinophile Granulom des Schädels. Klinikarzt 5:981–984.Google Scholar
  138. Braun-Falco O, Braun-Falco F (1957) Zum Syndrom „Diabetes insipidus und disseminierte Xanthome“. Z Laryngol Rhinol Otol 36:378–381.PubMedGoogle Scholar
  139. Braunstein G, Kohler P (1972) Pituitary function in Hand-Schüller-Christian disease. N Engl J Med 286:1225–1229.PubMedCrossRefGoogle Scholar
  140. Braunstein G, Whitacker J, Kohler P (1973) Cerebellar dysfunction in Hand-Schüller-Christian disease. Arch Intern Med 132:387–390.PubMedCrossRefGoogle Scholar
  141. Braunstein G, Raiti S, Hansen J, Kohler P (1975) Response of growth-retarded patients with Hand-Schüller-Christian disease to growth hormone therapy. N Engl J Med 292:332–333.PubMedCrossRefGoogle Scholar
  142. Chiari H (1931) Die generalisierte Xanthomatose vom Typus Schüller-Christian. Ergeb Allg Pathol Pathol Anat 24:396–401.Google Scholar
  143. Christian H (1920) Defects in membranous bones, exophthalmus and diabetes insipidus. Clin N Am 3:849–871.Google Scholar
  144. Christie A, Batson R, Shapiro J, Riley H, Laughmiller R, Stahlmann M (1954) Acute disseminated reticuloendotheliosis. Acta Paediatr 43:(Suppl 100), 65–76.CrossRefGoogle Scholar
  145. Cline M, Gold D (1973) A review and reevaluation of the histiocytotic disorders. Am J Med 55:49–58.PubMedCrossRefGoogle Scholar
  146. Corwin T, Greer D (1976) Prognathism in a patient with Hand-Schüller-Christian’s disease. Plast Reconstr Surg 57:513–516.PubMedCrossRefGoogle Scholar
  147. Dubach U, Wiesli B (1968) Histiocytosis X mit Diabetes insipidus, Vulva-Ulcerationen, Spontanpneumothorax, Hypothyreose und Exitus an Urämie. Schweiz Med Wochenschr 98:117–120.PubMedGoogle Scholar
  148. Dumermuth G (1958) Reticulogranulomatose:Zwei Fälle von eosinophilem Granulom mit Übergang in Hand-Schüller-Christiansche Erkrankung. Helv Paediatr Acta 13:15–37.PubMedGoogle Scholar
  149. Engelbreth-Holm J, Teilum G, Christensen E (1944) Eosinophil granuloma of bone — Schüller-Christian’s disease. Acta Med Scand 118:292–304.CrossRefGoogle Scholar
  150. Farquar J, Claireaux A (1952) Familiar haemophagocytic reticulosis. Arch Dis Child 27:519–525.CrossRefGoogle Scholar
  151. Finzi O (1929) Mieloma con prevalenza della cellule eosinofile, circoscritto all’osso frontale in un giovine di 15 anni. Minerva Med 9:239.Google Scholar
  152. Fitzpatrick T (1971) The Letterer-Siwe/Schüller-Christian syndromes. In:Fitzpatrick T, Arndt K, Clark W, Eisen A, Vanscott E, Vaughan J (eds) Dermatology in general medicine. McGraw Hill, New York, pp 440–454.Google Scholar
  153. Forsmann H, Rudberg B (1960) Study of consanguinity in 21 cases of Hand-Schüller-Christian disease. Acta Med Scand 168:427–429.CrossRefGoogle Scholar
  154. Garrahan J, Lascano Gonzales I, Gambirassi A, Magalhaes A (1944) Sobre el granuloma eosinofilico y la enfermaded de Schüller-Christian. Arch Argent Pediatr 22:3–19.Google Scholar
  155. Goldner M, Volk B (1955) Fulminant normocholesteremic xanthomatosis (histiocytosis X). Arch Intern Med 95:689–698.CrossRefGoogle Scholar
  156. Grady H, Stewart H (1934) Hand-Schüller-Christian’s disease and tuberculosis. Arch Pathol Lab Med 18:699–709.Google Scholar
  157. Grossfeld J, Fitzgerald J, Wagner V, Newton W, Baehner R (1976) Portal hypertension in infants and children with histiocytosis X. Am J Surg 131:108–113.CrossRefGoogle Scholar
  158. Hand A (1893) Polyuria and tuberculosis. Arch Pediatr 10:673–675.Google Scholar
  159. Imamura M, Muroya K (1971) Lymphnode ultrastructure in Hand-Schüler-Christian disease. Cancer 27:956–964.PubMedCrossRefGoogle Scholar
  160. Jaffe H (1972) Idiopathic inflammatory histiocytosis. In:Metabolic, degenerative and inflammatory diseases of bone and joints. Urban & Schwarzenberg, München Berlin Wien.Google Scholar
  161. Jaffe H, Lichtenstein L (1944) Eosinophilic granuloma of bone. Arch Pathol Lab Med 37:99–118.Google Scholar
  162. Jones A (1939) Schüller-Christian’s disease. Ann Intern Med 13:1068–1071.Google Scholar
  163. Jones B (1973) Chemotherapy of reticuloendotheliosis. Can Chemother Rep 57:110–116.Google Scholar
  164. Kaufmann A, Bukberg P, Werlin S, Young I (1976) Multifocal eosinophilic granuloma (Hand-Schüller-Christian disease). Am J Med 60:541–548.CrossRefGoogle Scholar
  165. Keizer P, Rochat R (1954) Malignant reticuloendotheliosis. Am J Dis Child 87:328–336.Google Scholar
  166. Kohout J (1972) Hand-Schüller-Christiansche Erkrankung mit Lungenbeteiligung. Prax Pneumol 26:381–387.PubMedGoogle Scholar
  167. Lahey M, Borges W, Evans A, Heyn R, Newton W (1970) Histiocytosis X:comparison of 3 treatment regimens in children. Proc Xth Int Can Congr, Abstract.Google Scholar
  168. Laymon C, Sevenants J (1948) Systemic reticulo-endothelial granuloma. Arch Dermatol Syph 57:873–876.CrossRefGoogle Scholar
  169. Letterer E (1948) Speicherungskrankheit. Dtsch Med Wochenschr 73:147–152.PubMedCrossRefGoogle Scholar
  170. Lever W (1963) Ablagerungskrankheiten körpereigener Stoffwechselprodukte. In:Gottron HA (Hrsg) Handbuch der Haut-und Geschlechtskrankheiten. Ergänzungswerk, Bd III/1:Nicht entzündliche Dermatosen I. Springer, Berlin Göttingen Heidelberg.Google Scholar
  171. Lever W (1967) Histopathology of the skin, 3rd ed. Lippincott, Philadelphia.Google Scholar
  172. Lever W, Leeper R (1950) Eosinophilic granuloma of the skin. Arch Dermatol Syph 62:85–89.CrossRefGoogle Scholar
  173. Lichtenstein L (1953) Histiocytosis X. Arch Pathol Lab Med 56:84–102.Google Scholar
  174. Lichtenstein L (1964) Histiocytosis X. J Bone Joint Surg [Am] 46:76–90.Google Scholar
  175. Mercer W, Duthie R (1956) Histiocytic granulomatosis. J Bone Joint Surg [Br] 38:279–282.Google Scholar
  176. Nierbauer G, Krawczyk W, Wilgram G (1970) Über die Langerhanszell-Organelle bei Morbus Letterer-Siwe. Arch Klin Exp Dermatol 239:125–130.CrossRefGoogle Scholar
  177. Nixon J, Perry J (1950) Reticuloendothelial hyperplasia of bone. J Int Coll Surg 13:788–790.PubMedGoogle Scholar
  178. Obermann H (1961) Idiopathic histiocytosis. Pediatrics 28:307–327.Google Scholar
  179. Ortiz A, Piantandi J, Barquin R, Moline F (1957) Neuroblastoma tipo Hutchinson. Arch Argent Pediatr 47:231–239.Google Scholar
  180. Rabinovich I, Degrossi O, Castells B (1958) Sindrome de Hans-Schüller-Christian y xanthomatosis ossea. Rev Argent Endocrinol 4:49–61.Google Scholar
  181. Rappaport H (1966) Tumors of haematopoetic system. Washington DC. Armed Forces Institute of Pathology.Google Scholar
  182. Rewald E (1960) Die Letterer-Christiansche Erkrankung. Ergeb Inn Med Kinderheilkd NF 13:143–174.Google Scholar
  183. Rowland R (1928) Xanthomatosis and the reticuloendothelial system. Arch Intern Med 42:611–673.CrossRefGoogle Scholar
  184. Ruch F (1957) Cutaneous manifestations of Letterer-Siwe’s disease. Arch Dermatol 75:88–91.CrossRefGoogle Scholar
  185. Schairer E (1938) Über eine eigenartige Erkrankung des kindlichen Schädels (Osteomyelitis mit eosinophiler Reaktion) Zentralbl Allg Pathol Pathol Anat 71:113–117.Google Scholar
  186. Schajowicz F, Polak M (1947) Contribucion al estudio del denominado “granuloma eosinofilico” y a sus relaciones con la xanthomatosis. Rev Asoc Med Argent 61:218–226.PubMedGoogle Scholar
  187. Schüller A (1915) Über eigenartige Defekte des Schädels im Jugendalter. Fortschr Röntgenstr. 23:12–18.Google Scholar
  188. Schulze E, Schnepper E (1967) Erfahrungen bei der Diagnose und Behandlung des eosinophilen Knochengranuloms mit besonderer Berücksichtigung der Telekobalt-Strahlentherapie. Strahlentherapie 132:173–183.PubMedGoogle Scholar
  189. Siwe S (1933) Die Reticuloendotheliose — ein neues Krankheitsbild unter den Hepatosplenomegalien. Z Kinderheilkd 55:212–247.CrossRefGoogle Scholar
  190. Smith C (1972) Blood diseases of infancy and childhood, 3rd ed. Mosby, Saint Louis.Google Scholar
  191. Souquet R (1967) Evolution et traitement de l’histiocytosis X pulmonaire de l’adulte. Rev Tuberc (Paris) 31:637.Google Scholar
  192. Starling K, Fernbach D (1973) Histiocytosis. In:Sutow WW (ed) Clinical pediatric oncology. Mosby, Saint Louis, pp 320.Google Scholar
  193. Starling K, Donaldson M, Haggard M, Vietti T, Sutow W (1972) Therapy of histiocytosis X with vincristine, vinblastine and cyclophosphamide. Am J Dis Child 123:105–110.PubMedGoogle Scholar
  194. Takahashi M, Martel W, Oberman H (1966) The variable roentgenographic appearance of idiopathic histiocytosis. Clin Radiol 17:48.PubMedCrossRefGoogle Scholar
  195. Thannhäuser S (1950) Lipoidoses. “Disease of the cellular lipid metabolism”. Oxford Med Publ.Google Scholar
  196. Thannhäuser S, Magendantz H (1938) The different clinical groups of xanthomatous diseases. Ann Intern Med 11:1662–1746.Google Scholar
  197. Thompson DM (1975) Hand-Schüller-Christian disease of scalp and vulva. Proc R Soc Med 68:761–762.PubMedGoogle Scholar
  198. Turiaf J, Basset F (1967) Pulmonale Histiocytose X. Münch Med Wochenschr 109:805–815.PubMedGoogle Scholar
  199. Wachtler F (1961) Über die Strahlenbehandlung des eosinophilen Knochengranuloms. Krebsarzt 16:193–197.PubMedGoogle Scholar
  200. Wang S (1956) Letterer-Siwe’s disease and eosinophilic granuloma of bones. J Int Coll Surg 25:503–509.PubMedGoogle Scholar
  201. Walthardt B (1958) Hand-Schüller-Christiansche Krankheit, Cholesterinspeicherkrankheit des Erwachsenen. Schweiz Med Wochenschr 88:294–295.Google Scholar
  202. Weber W, Margolin F, Nielsen S (1969) Pulmonary histiocytosis X. Am J Roentgenol 107:280–283.Google Scholar
  203. Winkelmann RK (1969) The skin in histiocytosis X. Mayo Clin Proc 44:535–539.PubMedGoogle Scholar
  204. Wolff H, Braun-Falco O (1972) Zur Diagnostik und Therapie des Morbus Hand-Schüller-Christian. Hautarzt 23:163–175.PubMedGoogle Scholar
  205. Zöllner N (1964) Die Speicherkrankheiten des reticuloendothelialen Systems. In:Herlmeyer G, Hiltmair W (Hrsg) Handbuch der gesamten Hämatologie, Bd V/3/1. Urban & Schwarzenberg, Berlin-München, S 20.Google Scholar
  206. Abul-F-Adl MA, King E (1949) Properties of the acid phosphatases of erythrocytes and human prostate gland. Biochem J 45:51.Google Scholar
  207. Albrecht M (1966) „Gaucher Zellen“ bei chronisch myeloischer Leukämie. Blut 13:169–179.PubMedCrossRefGoogle Scholar
  208. Amstutz H, Carey E (1966) Skeletal manifestations and treatment of Gaucher’s disease. J Bone Joint Surg (Am) 48:770–7.Google Scholar
  209. Baer I, Zimmermann H (1967) Der Morbus Gaucher beim Erwachsenen. Dtsch Gesundh 28:1297–1301.Google Scholar
  210. Barton N, Rosenberg A (1975) Metabolism of glucosyl(H3)ceramid by human skin fibroblasts from normal and glucosylceramidotic subjects. J Biol Chem 250:3966–3971.PubMedGoogle Scholar
  211. Bessis M (1956) Cytology of the blood and blood-forming organs. Grune & Stratton, New York London.Google Scholar
  212. Beutler E, Kuhl W (1970) The diagnosis of the adult type of Gaucher’s disease and its carrier state by demonstration of deficiency of β-glucosidase activity in peripheral blood leucocytes. J Lab Clin Med 76:747–755.PubMedGoogle Scholar
  213. Bird A (1948) Die Lipidosen und das zentrale Nervensystem. Brain 71:434.PubMedCrossRefGoogle Scholar
  214. Block M, Jacobson L (1978) The histiogenesis and diagnosis of the osseous type of Gaucher’s disease. Acta Haemat (Basel) 1:165.CrossRefGoogle Scholar
  215. Boklan B, Savitsky A (1976) Factor IX deficiency in Gaucher disease. Arch Intern Med 136:489–492.PubMedCrossRefGoogle Scholar
  216. Boudet CH, Costeau J, Raynaud J (1966) Opacities cornéennes et maladie de Gaucher. Bull Soc Ophthalmol Fr 66:443.Google Scholar
  217. Brady RO (1970) Cerebral lipodoses. Ann Res Med 21:317–331.CrossRefGoogle Scholar
  218. Brady RO (1971) Identification of heterozygous carriers of lipid storage disease. Am J Med 51:423–431.PubMedCrossRefGoogle Scholar
  219. Brady RO, Pentchev P, Gal A, Hibbert S, Dekaban AS (1974) Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher’s disease. N Engl J Med 291:989–993.PubMedCrossRefGoogle Scholar
  220. Carbone A, Petrozzi C (1968) Gaucher’s disease:case with stress on eye findings. Henry Ford Hosp Med J 16:55.PubMedGoogle Scholar
  221. Chang-Lo M, Yam L, Rubenstone A (1967) Gaucher’s disease. Am J Med Sci 254:303–315.PubMedCrossRefGoogle Scholar
  222. Cho SY, Sastre M (1976) Coexistence of Hodgkin’s disease and Gaucher’s disease. Am J Clin Pathol 65.103–108.PubMedGoogle Scholar
  223. Crocker A, Landing B (1960) Phosphatase studies in Gaucher’s disease. Metabolism 9:341–446.PubMedGoogle Scholar
  224. Davies FWT (1954) Gaucher’s disease. J Bone Joint Surg 34:454.Google Scholar
  225. DeLange C (1940) Über die maligne Form der Gaucherschen Krankheit. Acta Paediatr Scand 27:34–40.CrossRefGoogle Scholar
  226. Diezel PB (1955) Histochemische Untersuchungen an den Globoidzellen der familiären infantilen diffusen Sklerose vom Typ Krabbe (zugleich eine differentialdiagnostische Betrachtung der zentralnervösen Veränderungen beim Morbus Gaucher). Virchows Arch Pathol Anat 327:206–211.CrossRefGoogle Scholar
  227. East T, Savin L (1940) A case of Gaucher’s disease with biopsy of the typical pingueculae. Br J Ophthalmol 24:611–613.PubMedCrossRefGoogle Scholar
  228. Edlin P, Kepler W, Knabe G (1955) Gaucher’s disease. Gastroenterology 28:120–123.PubMedGoogle Scholar
  229. Fienberg M, Qigley G (1946) Osseous Gaucher’s disease with macrocytic normochromic anemia. N Engl J Med 234:527.PubMedCrossRefGoogle Scholar
  230. Fisher E, Reidbord H (1962) Gaucher’s disease. Am J Pathol 41:679–692.PubMedGoogle Scholar
  231. Fredrickson DS, Sloan HR (1972) Glucosyl ceramide lipidoses. Gaucher’s disease. In:Stanburry J, Wyngaarden J, Fredrickson DS (eds) The metabolic basis of inherited disease. McGraw Hill, New York, pp 620.Google Scholar
  232. Fried K (1973) Population study of chronic Gaucher’s disease. Isr J Med Sci 9:1396–1398.PubMedGoogle Scholar
  233. Gaucher PCE (1882) De l’épithéliome primitif de la rate. Thèse, Paris.Google Scholar
  234. Girgensohn H, Kellner H, Südhof H (1954) Angeborener Morbus Gaucher bei Erythroblastose und Gefäßverkalkung. Klin Wochenschr 32:57–64.PubMedCrossRefGoogle Scholar
  235. Goldberg A, Takakura K, Rosenthal R (1966) Electrophoretic separation of serum acid phosphatase isoenzymes in Gaucher’s disease, prostatic carcinoma and multiple myeloma. Nature 211:341–349.CrossRefGoogle Scholar
  236. Gordon GL (1950) Osseous Gaucher’s disease. Am J Med 8:332–334.PubMedCrossRefGoogle Scholar
  237. Groen J, Garrer A (1948) Hereditary mechanism of Gaucher’s disease. Blood 3:1221–1237.PubMedGoogle Scholar
  238. Hayduk K, Eggstein M, Waller H (1968) Morbus Gaucher mit Glutathionreduktase-Mangel in den Blutzellen. Dtsch Med Wochenschr 93:1063–1066.PubMedCrossRefGoogle Scholar
  239. Herndorn C, Bender J (1950) Gaucher’s disease in 5 related negroe sibships. Am J Hum Genet 2:49–60.Google Scholar
  240. Hibbs R, Ferrans V, Cipriano P, Tardiff K (1970) A histochemi-and electron microscopic study of Gaucher cells. Arch Pathol Lab Med 89:137–152.Google Scholar
  241. Ho M, Seck J, Schmidt D, Veath L, Johnson W, Brady R, O’Brian J (1972) Adult Gaucher’s disease:Kindred studies and demonstration of a deficiency of acid β-glucosidase in cultured fibroblasts. Am J Hum Genet 24:37–45.PubMedGoogle Scholar
  242. Hoffmann S, Makler M (1929) Gaucher’s disease. Am J Dis Child 38:775–793.Google Scholar
  243. Hsia D, Naylor J, Bigler J (1959) Gaucher’s disease. N Engl J Med 261:164–167.PubMedCrossRefGoogle Scholar
  244. Jatzkewitz K (1970) Zerebrale Sphingolipidosen als angeborene Stoffwechselstörung. Dtsch Med Wochenschr 3:131–137.CrossRefGoogle Scholar
  245. Junghägen S (1926) Gaucher’s disease with roentgenological demonstrable skeletal changes. Acta Radiol (Stockh) 5:506.CrossRefGoogle Scholar
  246. Kahlke W (1973) Gauchersche Krankheit. In:Bock HE (Hrsg) Klinik der Gegenwart — Handbuch der praktischen Medizin. Urban & Schwarzenberg, München Berlin Wien.Google Scholar
  247. Kampine J, Brady R, Kanfer J, Feld M, Shapiro D (1967) Diagnosis of Gaucher’s disease and Niemann-Pick disease with small samples of venous blood. Science 155:86–88.PubMedCrossRefGoogle Scholar
  248. Kattlove H, Williams J, Caynor E, Spivack M, Bradley R, Brady R (1969) Gaucher cells in chronic myelotic leucemia:an acquired abnormality. Blood 33:379–389.PubMedGoogle Scholar
  249. Katz J (1967) Recurrent avascular necrosis of the proximal femoral epiphysis in the same hip in Gaucher’s disease. J Bone Joint Surg 49:514–518.PubMedGoogle Scholar
  250. Klenk E (1940) Zur Chemie der Lipoidosen, Gauchersche Krankheit. Z Physiol Chem 267:128–134.CrossRefGoogle Scholar
  251. Knudson A, Kaplan W (1962) Genetics of the sphingolipidoses. In:Aronson S, Volk B (eds) Cerebral sphingolipidosis. Academic Press, New York London, pp 170.Google Scholar
  252. Kopaczyk K, Radin N (1965) In vivo conversions of cerebroside and ceramid in rat brain. J Lipid Res 6:140.PubMedGoogle Scholar
  253. Lee R, Balcerak S, Westerman M (1967) Gaucher’s disease:a morphologic study and measurement of iron metabolism. Am J Med 42:891–898.PubMedCrossRefGoogle Scholar
  254. Levin B (1961) Gaucher’s disease:clinical and roentgenologic manifestations. Am J Roentgenol 85:685–689.Google Scholar
  255. Lieb H (1927) Cerebrosidspeicherung bei Splenomegalie Typ Gaucher. Z Physiol Chem 170:60–66.CrossRefGoogle Scholar
  256. Lorber M (1960) The occurence of intracellular iron in Gaucher’s disease. Ann Intern Med 53:293–295.PubMedGoogle Scholar
  257. Maloney A, Cumings J (1960) A case of juvenile Gaucher’s disease with intraneuronal lipid storage. J Neurol Neurosurg Psychiatry 23:207–212.PubMedCrossRefGoogle Scholar
  258. Mandelbaum F (1919) Two cases of Gaucher’s disease in adults:study of histopathology, biology and chemical findings. Am J Med Sci 157:366–389.CrossRefGoogle Scholar
  259. Matoth Y, Fried K (1965) Chronic Gaucher’s disease. Clinical observations on 34 patients. Isr J Med Sci 1:521–534.PubMedGoogle Scholar
  260. Minauf M, Stögmann W, Krepler P, Seitelberger F (1970) Zur Beteiligung des ZNS beim infantilen Morbus Gaucher. Klinik und Neuropathologie. Arch Kinderheilkd 181:85–93.PubMedGoogle Scholar
  261. Morrison A, Lane M (1955) Gaucher’s disease with ascites:case report with autopsy findings. Ann Intern Med 42:1321–1329.PubMedGoogle Scholar
  262. Nishimura K, Yamaka T (1968) Isolation of cerebroside containing glucose and its possible significance in ganglioside synthesis. Lipids 3:262–269.PubMedCrossRefGoogle Scholar
  263. Öckermann P (1968) Identity of β-glucosidase, β-xylosidase and one of the β-galactosidase activities in human liver when assayed with 4-methylumbelliferyl-β-D-glycosides. Studies in case of Gaucher’s disease. Biochem Biophys Acta 165:59–62.CrossRefGoogle Scholar
  264. Pentchev P, Brady R, Hibbert S, Gal A, Shapiro D (1973) Isolation and characterization of glucocerebrosidase from human placental tissue. J Biol Chem 248:5256–5261.PubMedGoogle Scholar
  265. Philippart M, Rosenstein B, Menkes J (1965) Isolation and characterization of the main splenic glycolipids in the normal organ and in Gaucher’s disease:Evidence for the site of metabolic block. J Neuropathol Exp Neurol 24:290–303.PubMedCrossRefGoogle Scholar
  266. Pick L (1924) Der Morbus Gaucher und die ihm ähnlichen Erkrankungen. Ergeb Inn Med 29:519.Google Scholar
  267. Pinnelli N, Scaravilli F, Zacchelo F (1969) The morphogenesis of Gaucher’s cells investigated by electron microscopy. Blood 34:331–347.Google Scholar
  268. Pratt P, Estern S, Kochwa S (1968) Immunglobulin abnormalities in Gaucher’s disease. Blood 31:633–640.PubMedGoogle Scholar
  269. Reich C, Seife M, Kessler B (1951) Gaucher’s disease. Medicine 30:1–20.PubMedCrossRefGoogle Scholar
  270. Reiss O, Kato K (1932) Gaucher’s disease. Clinical study with special reference to roentgenography of bones. Am J Dis Child 43:365–386.Google Scholar
  271. Rhagavan S, Mumford R, Kanfer J (1973) Deficiency of β-glucosidase in Gaucher disease. Biochem Biophys Res Commun 54:256–263.CrossRefGoogle Scholar
  272. Rhagavan S, Mumford R, Kanfer J (1974) Isolation and characterization of glucosylsphingosine from Gaucher’s spleen. J Lipid Res 15:484–490.Google Scholar
  273. Rodnan G, McEwen C, Wallace S (1973) Primer on the rheumatic disease. JAMA [Suppl 5] 224:768.CrossRefGoogle Scholar
  274. Rosenberg A, Chargaff E (1958) A reinvestigation of the cerebroside deposid in Gaucher’s disease. J Biol Chem 233:1323–1326.PubMedGoogle Scholar
  275. Rossner F, Dosik H, Kaiser S, Lee S, Morrison A (1969) Gaucher’s cells in leukemia. JAMA 209:935–937.CrossRefGoogle Scholar
  276. Rourke JA, Heslin DJ (1965) Gaucher’s disease. Roentgenologic bone changes. Am J Roentgenol Radium Ther Nucl Med 94:621–626.PubMedGoogle Scholar
  277. Rusca CL (1921) Sul morbo del Gaucher. Haematologica 2:441.Google Scholar
  278. Schettler G (1976) Morbus Gaucher. In:Schettler G, Greten H, Schlierf G, Seidel D (Hrsg) Handbuch der inneren Medizin, 5. Aufl Bd VII/4:Fettstoffwechsel. Springer, Berlin Heidelberg New York, S 547–564.Google Scholar
  279. Schettler G, Kahlke W (1967) Gaucher’s disease. In:Schettler G (ed) Lipids and lipidoses. Springer, Berlin Heidelberg New York, pp 260–287.CrossRefGoogle Scholar
  280. Seitelberger F (1964) About the brain involvement in Gaucher’s disease in children. Arch Psychiatr Nervenkr 206:419–423.PubMedCrossRefGoogle Scholar
  281. Silverstein M, Kelly P (1967) Osteoarticular manifestations of Gaucher’s disease. Am J Med Sci 253:569–571.PubMedCrossRefGoogle Scholar
  282. Streifler C (1970) Study of acid phosphatase in sera of Gaucher’s disease patients, subcellular tissue fractions and platelet extracts. Isr J Med Sci 6:479.PubMedGoogle Scholar
  283. Suomi W, Agranoff B (1965) Lipids of the spleen in Gaucher’s disease. J Lipid Res 6:211–219.PubMedGoogle Scholar
  284. Thannhäuser SJ (1950) Lipidoses:Disease of cellular lipid metabolism. Oxford Press, New York.Google Scholar
  285. Tuchmann L, Suna H, Carr J (1956) Elevation of serum acid phosphatase in Gaucher’s disease. J Mt Sinai Hosp 23:227–229.Google Scholar
  286. Volk B, Wallace B (1967) The liver in lipidoses. An electron microscopic and histochemical study. Am J Pathol 49:203–225.Google Scholar
  287. Weinschenk C (1964) Über die Psychopathologie der juvenilen Form eines Morbus Gaucher (mit Falldemonstration). Med Welt 15:140.Google Scholar
  288. Wintrobe MM (1974) Gaucher’s disease. In: Clinical hematology, 7th ed. Lea & Lebiger, Philadelphia, ed Wintrobe MM, pp 247.Google Scholar
  289. Wohlenberg H (1972) Splenomegalie, Thrombopathie und Erhöhung der sauren Phosphatase. Dtsch Med Wochenschr 97:1398–1400.PubMedCrossRefGoogle Scholar
  290. Yossipovitch ZH, Hermann G, Makin M (1965) Aseptic osteomyelitis in Gaucher’s disease. Isr J Med Sci 1:531–532.PubMedGoogle Scholar
  291. Zaino E, Rossi M, Pham TD, Azar H (1971) Gaucher’s cells in thalassemia. Blood 38:457–461.PubMedGoogle Scholar
  292. Zöllner N (1964) Gauchersche Krankheit. In:Heilmeyer L, Hittmair (Hrsg) Handbuch der gesamten Hämatologie. Urban & Schwarzenberg, München Berlin, pp 220.Google Scholar
  293. Blomstrand R, Juhlin L, Nordenstam H, Ohlson R, Werner B, Engström J (1971) Adiposis dolorosa associated with defects of lipid metabolism. Acta Derm Venerol (Stockh) 243-250.Google Scholar
  294. Brunner W (1934) Beitrag zur Pathogenese der multiplen, symmetrischen Lipomatose. Dtsch Z Chir 244:335–338.Google Scholar
  295. Bufalini P (1923) Sulla istogenesi del collo grasso di Madelung. Zentralbl Gesamte Chir 36:1414.Google Scholar
  296. Cantu JM, Ruiz-Barquin E, Jiminez M, Castillo L, Macotela-Ruiz E (1973) Autosomal dominant inheritance in adiposis dolorosa (Dercum’s disease). Humangenetik 18:89–91.PubMedGoogle Scholar
  297. Dercum FX (1892) Adiposis dolorosa. Am J Med Sci 104:521–535.CrossRefGoogle Scholar
  298. Dercum FX, McCarthy DJ (1902) Autopsie in a case of adiposis dolorosa. Am J Med Sci 124:994–1006.CrossRefGoogle Scholar
  299. Fitzpatrick TB (1971) Adiposis dolorosa. In:Arndt KA, Clark WH, Eisen AZ, Vanscott EJ, Vaughan JH (eds) Dermatology in general medicine. McGraw Hill, New York, pp 215.Google Scholar
  300. Fritzsch W (1951) Ein Beitrag zur Lipomatosis dolorosa. Arch Geschwulstforsch 3:204–212.Google Scholar
  301. Günther H (1920) Die Lipomatose und ihre klinischen Formen. Arbeit. Med Klin Leipzig H5.Google Scholar
  302. Günther H (1929) Die Beziehung des Geschlechts zur Geschwulstbildung. Z Krebsforsch 29:91–111.Google Scholar
  303. Hall JN, Wallbrach CE (1904) Adiposis dolorosa. Am J Med Sci 128:318–323.CrossRefGoogle Scholar
  304. Hovensen E (1953) Adipositas dolorosa (Dercums Syndrom). Nord Med 50:971–977.Google Scholar
  305. Iwane T, Maruyama M, Matsuki M, Ho Y, Shimoji K (1976) Management of intractable pain in adiposis dolorosa with i.v. administration of lidocain. Anaesth Analg 55:257–259.CrossRefGoogle Scholar
  306. Kling DH (1937) Juxta-articular adiposis dolorosa:its significant relation to Dercum’s disease and osteo-arthritis. Arch Surg 34:559–630.Google Scholar
  307. Korting GW, Denk R (1974) Dermatologische Differentialdiagnose. Schattauer, Stuttgart New York.Google Scholar
  308. Luchetta B (1939) Symmetrische Lipomatose. Zentralbl Pathol 71:373.Google Scholar
  309. Lynch HT, Harlan WL (1963) Hereditary factors in adiposis dolorosa. Am J Hum Genet 15:184–190.PubMedGoogle Scholar
  310. Mella BA (1967) Adiposis dolorosa. Univ Mich Med Center J 33:79–84.Google Scholar
  311. Michailov ML (1975) Multiple Lipomatose und von Recklinghausensche Neurofibromatose. Med Klin 70:151–153.PubMedGoogle Scholar
  312. Nödl F (1974) Lipomatose. Dtsch Med Wochenschr 99:1427–1432.PubMedGoogle Scholar
  313. Page IH (1931) Chemiche Untersuchungen bei der Dercumschen Krankheit. Virchows Arch [Pathol Anat] 279:262–264.Google Scholar
  314. Price GE (1909) Adiposis dolorosa. Am J Med Sci 137:705–715.CrossRefGoogle Scholar
  315. Ries W (1970) Fettsucht. Barth, Leipzig.Google Scholar
  316. Ruiter M, Pompen A, Wyers H (1948) Granulomatöse Panvasculitiden mit ausschließlich cutansubcutaner Lokalisation. Dermatologica (Basel) 97:257–264.CrossRefGoogle Scholar
  317. Schwerdtner U (1974) Kasuistische Mitteilung zur Lipomatosis dolorosa. Z Inn Med 29:726–728.Google Scholar
  318. Steiger W, Litvin H, Lasche E, Durant T (1952) Adiposis dolorosa. N Engl J Med 247:393–396.PubMedCrossRefGoogle Scholar
  319. Stern H (1910) Adiposis dolorosa with myxedematous manifestations. Am J Med Sci 139:359–363.CrossRefGoogle Scholar
  320. Wachs E (1952) Zur Behandlung der Lipomatosis dolorosa Dercum. Zentralbl Chir 42:1787–1792.Google Scholar
  321. Wilson CL (1933) Adiposis dolorosa. Am J Surg 19:485–488.CrossRefGoogle Scholar
  322. Wohl MG, Pastor N (1938) Adiposis dolorosa (Dercum’s disease):treatment of asthenie phase with prostagmine and aminoacetic acid. JAMA 110:1261–1264.CrossRefGoogle Scholar
  323. Andreas E (1949) Die Lipocalcinogranulomatose — eine neue Lipoidose. Med Klin 29:913–916.Google Scholar
  324. Apak S (1958) Lipocalcinogranulomatose (Teutschländersche Krankheit). Z Kinderheilkd 81:348–366.PubMedCrossRefGoogle Scholar
  325. Batz F (1942) Dissertation, Heidelberg.Google Scholar
  326. Blume P (1954) Lipoidkalkgicht und Encephalitis. Arch Kinderheilkd 148:276–281.PubMedGoogle Scholar
  327. Briggs JN, Illingworth RS (1952) Calcinosis universalis treated with adrenocorticotrophic hormone and cortisone. Lancet II:800–802.CrossRefGoogle Scholar
  328. Fuhrmann W (1967) Genetic aspects of lipidoses. In:Schettler G (Hrsg) Lipids and lipidoses. Springer, Berlin Heidelberg New York, pp 490–528.CrossRefGoogle Scholar
  329. Gassinger H (1946) Lipocalcinogranulomatose. Dissertation, Heidelberg.Google Scholar
  330. Hübner G, Seydel-Ansorge S (1975) Beitrag zum Krankheitsbild der Lipocalcinogranulomatose. Zentralbl Allg Pathol 119:15–21.PubMedGoogle Scholar
  331. Jansen HH (1962) Lipocalcinogranulomatosis Teutschländer. Zentralbl Allg Pathol 103:559.Google Scholar
  332. Jesserer H (1960) Erkrankungen und Probleme aus den Grenzgebieten der Inneren Medizin. XVII. Calcinosis interstitialis (Kalkgicht). Med Klin 55:2229–2234.PubMedGoogle Scholar
  333. Korting GW, Denk R (1974) Dermatologische Differentialdiagnose. Schattauer, Stuttgart, New York.Google Scholar
  334. Marchand A (1910) Calcinosis universalis (Demonstration pathologisch anatomischer Präparate). Münch Med Wochenschr 2:103.Google Scholar
  335. Nerreter W (1957) Kasuistischer Beitrag zur Lipoidthesaurismose. Die Med 26:980–984.Google Scholar
  336. Osthuizen SF, Roux P Le, Wett AS De (1950) Calcinosis universalis:type lipo-calcinogranulomatosis. Br J Radiol 23:598–600.CrossRefGoogle Scholar
  337. Paucke A (1935) Calcinosis interstitialis universalis. Fortschr Roentgenstr 51:602–608.Google Scholar
  338. Reich H (1963) Das Teutschländer Syndrom. Hautarzt 14:462–468.PubMedGoogle Scholar
  339. Sommer F, Tress E (1941) Beitrag zum Krankheitsbild der Lipocalcinogranulomatose. Fortschr Röntgenstr 63:205–214.Google Scholar
  340. Steinitz H (1930) Kalkgicht und Calcinosis universalis. Klin Wochenschr 35:1632–1634.CrossRefGoogle Scholar
  341. Teutschländer O (1935) Über progressive Lipogranulomatose der Muskulatur. Klin Wochenschr 14:451–453.CrossRefGoogle Scholar
  342. Teutschländer O (1941) Epithelkörperchen-und Knochenveränderungen bei fortschreitender Lipocalcinogranulomatose (Lipogranulomatosa progrediens). Klin Wochenschr 28:714–716.CrossRefGoogle Scholar
  343. Teutschländer O (1949) Die Lipoido-Calcinosis oder Lipoidkalkgicht (Lipocalcinogranulomatose). Beitr Pathol 110:402–432.Google Scholar
  344. Traca G, Hennebert PN, Mazabraud A (1965) Considération sur un cas de lipocalcinogranulomatose. Presse Med 10:543–546.Google Scholar
  345. Ahrens EH, Kunkel HG (1949) The relationship between serum lipids and skin xanthomata in eighteen patients with primary biliary cirrhosis. J Clin Invest 28:1565–1572.PubMedCrossRefGoogle Scholar
  346. Arnold W (1943) Die Kerne der Schaumzellen. Beitr Pathol 108:1–34.Google Scholar
  347. Aschoff L (1925) Vorträge über Pathologic Fischer Jena.Google Scholar
  348. Baes H, Gent CM van, Pries C (1968) Lipid composition of various types of xanthoma. J Invest Dermatol 51:286–292.PubMedGoogle Scholar
  349. Braun-Falco O (1973) Origin, structure and function of the xanthoma cell. Nutr Metab 15:66–88.Google Scholar
  350. Braun-Falco O (1976) Struktur und Morphogenese von Xanthomen bei Hyperlipoproteinämie vom Typ III. Hautarzt 27:122–132.PubMedGoogle Scholar
  351. Cornelius CE (1970) Xanthomata in primary hyperlipoproteinemia. Arch Dermatol 101:701–702.PubMedCrossRefGoogle Scholar
  352. Curtis AC, Bleylock HC (1952) Secondary eruptive xanthomatosis due to myxedemia. Arch Dermatol 66:460–465.CrossRefGoogle Scholar
  353. Epstein NN, Rosenman RH, Gofman JW (1952) Serum lipoprotein and cholesterol metabolism in xanthelasma. Arch Dermatol 65:70–81.CrossRefGoogle Scholar
  354. Fanta D, Forman I, Niebauer G (1971) Das Verhalten der Lipoproteine bei den Xanthomatosen. Wien Klin Wochenschr 83:313–318.PubMedGoogle Scholar
  355. Fletcher RF (1973) Lipid composition of xanthomas of different types. Nutr Metab 15:97–106.PubMedCrossRefGoogle Scholar
  356. Fletcher RF, Gloster J (1964) The lipids in xanthomata. J Clin Invest 43:2104–2111.PubMedCrossRefGoogle Scholar
  357. Fredrickson DS (1971) Plasma lipid abnormalities in cutaneous xanthomas. In:Fitzpatrick TB, Arndt KA, Clark WH Jr, Eisen AZ, Vanscott EJ, Vaughan JA (eds) Deramtology in general medicine. McGraw Hill, New York, S 315–320.Google Scholar
  358. Fredrickson DS (1972) Hyperlipoproteinemia. In:Stanburry JB, Wyngarden JB, Fredrickson DS (eds) The metabolic basis of inherited disease, 3rd ed. McGraw Hill, New York, S 416–420.Google Scholar
  359. Fredrickson DS, Lee RS (1965) A system of phenotyping hyperlipoproteinemia. Circulation 31:321–327.PubMedGoogle Scholar
  360. Glueck CJ, Levy RI, Fredrickson DS (1968) Acute tendinitis and arthritis. JAMA 206:2895–2897.PubMedCrossRefGoogle Scholar
  361. Gofman JW, Rubin L, McGinley JP, Jones HB (1954) Hyperlipoproteinemia. Am J Med 17:514–520.PubMedCrossRefGoogle Scholar
  362. Heiberg A (1975) The lipoprotein and lipid pattern in xanthomatosis. Acta Med Scand 198:183–195.PubMedCrossRefGoogle Scholar
  363. Jansen HH (1967) Klinische Pathologie der Xanthomatosen. Münch Med Wochenschr 109:768–776.PubMedGoogle Scholar
  364. Kachadurian AK (1968) Migratory polyarthritis in familial hypercholesterinemia (type II hyperlipoproteinemia). Arthritis Rheum 11:385–393.CrossRefGoogle Scholar
  365. Kachadurian AK, Uthmann SM (1973) Experiences with the homocygeous cases of familial hypercholesterolemia. A report of 52 patients. In:Braun-Falco O, Keller CH, Zöllner N (eds) Xanthomatious formations and other tissue reactions to hyperlipidemias. Karger, Basel München Paris London New York Sydney, S 86–94.Google Scholar
  366. Kahlke W (1966) Differenzierung der essentiellen Hyperlipoproteinämien (Hyperlipidämien). Dtsch Med Wochenschr 91:26–29.PubMedCrossRefGoogle Scholar
  367. Lever WF (1966) Histopathology of the skin, 4th ed. Lippinscott, Philadelphia.Google Scholar
  368. Levy RI, Fredrickson DS (1968) Diagnoses and management of hyperlipoproteinemia. Am J Cardiol 22:576–583.PubMedCrossRefGoogle Scholar
  369. Levy RI, Fredrickson DS (1970) The current status of hypolipidemic drugs. Postgrad Med 47:130–137.PubMedGoogle Scholar
  370. Lynch PJ, Winkelmann RK (1966) Generalized plane xanthoma and systemic disease. Arch Dermatol 93:639–646.PubMedCrossRefGoogle Scholar
  371. Oster P, Schlierf G, Henk C, Greten H, Gendert-Remy U, Haase K, Klose G, Nothelfer N, Raetzler H, Schellenberg B (1976) Sitosterol in type II hyperlipoproteinemia. In:Greten H (eds) Lipoprotein metabolism. Springer, Berlin, Heidelberg, New York, pp 125–130.CrossRefGoogle Scholar
  372. Parker F (1975) Some observations on human xanthomas and what they are revealed about the interaction of lipoproteins with the skin. Am Derm Assoc 95th meeting, Palm Beach, Florida 1975, Abstract.Google Scholar
  373. Parker F, Odland GF (1969) Electron microscopic similarities between experimental xanthomas and human eruptive xanthomas. J Invest Dermatol 52:136–147.PubMedGoogle Scholar
  374. Parker F, Short JM (1970) Xanthomatosis associated with hyperlipoproteinemia. J Invest Dermatol 55:71–88.PubMedCrossRefGoogle Scholar
  375. Parker F, Peterson N, Odland GF (1966) A comparison of cholesterol ester fatty acid patterns in the blood and in evolving xanthoma and atheroma during cholesterol feeding of rabbits. J Invest Dermatol 47:253–259.PubMedGoogle Scholar
  376. Polano MK (1973) Xanthoma types in relation of hyperlipoproteinemia. Nutr Metab 15:107–118.PubMedCrossRefGoogle Scholar
  377. Polano MK (1974) Xanthomatosis and hyperlipoproteinemia. Dermatologica 149:1–9.PubMedCrossRefGoogle Scholar
  378. Polano MK, Baes H, Hulsman H, Querido A, Pries C, Gent CM van (1969) Xanthomata in primary hyperlipoproteinemia. Arch Dermatol 100:387–398.PubMedCrossRefGoogle Scholar
  379. Rifkind BM (1973) Clinics in endocrinology and metabolism. Vol 2. Saunders, London Philadelphia Toronto.Google Scholar
  380. Rufli T, Stähelin H (1972) Xanthomatosen als Symptom von hyperlipidämischen Stoffwechselstörungen. Dermatologica 144:270–282.PubMedCrossRefGoogle Scholar
  381. Schettler G, Greten H, Schlierf G, Seidel D (Hrsg) (1976) Handbuch der inneren Medizin, 5. Aufl Bd VII/4:Fettstoffwechsel. Springer, Berlin Heidelberg New York.Google Scholar
  382. Thannhäuser SJ (1948) Klassifizierung der xanthomatösen Erkrankungen. Aerztl Forsch 11:295–301.Google Scholar
  383. Walton KW, Dunkerley C, Dunkerley T, Dunkerley D (1973) The pathogenesis of xanthomata. J Pathol 109:271–288.PubMedCrossRefGoogle Scholar
  384. Weizel A (1973) Isotopic equilibration between plasma 4-14C-cholesterol and free and esterified cholesterol in xanthoma of hyperlipidemic patients. Nutr Metab 15:42–45.PubMedCrossRefGoogle Scholar
  385. Wolff HH, Braun-Falco O (1970) Die Ultrastruktur des Xanthelasma palpebrarum. Arch Klin Exp Dermatol 283:308–322.CrossRefGoogle Scholar
  386. Wolfram G (1973) Reversibility of lipid deposition. Nutr Metab 15:141–143.PubMedCrossRefGoogle Scholar
  387. Zöllner N (1973) Principles of drug therapy of hyperlipidemic xanthomatous diseases. Nutr Metab 15:144–150.PubMedCrossRefGoogle Scholar
  388. Zöllner N, Wolfram G (1970) Die Behandlung der Xanthome bei Hypercholesterinämie. Hautarzt 21:443–445.PubMedGoogle Scholar
  389. Brenner W, Schaefler K, Chhabra H, Postel A (1975) Dermatofibrosarcoma protuberans metastatic to a regional lymph node. Cancer 36:1897–1902.PubMedCrossRefGoogle Scholar
  390. Delamater J (1859) Cleve Med Gazette 1:1. Zit nach Tedeschi (1965).Google Scholar
  391. Duhig JT, Ayer JP (1959) Vascular leiomyoma. Arch Pathol 68:424–430.PubMedGoogle Scholar
  392. Ehlers G (1968) Allgemeine Pathologie des Fettgewebes. In:Gans O, Steigleder GK (Hrsg) Handbuch der Haut-und Geschlechtskrankheiten. Ergänzungswerk, Bd I/1, normale und pathologische Anatomie der Haut I. Springer, Berlin Heidelberg New York, S 787–861.Google Scholar
  393. Enzinger FM (1969) Histological typing of soft tissue tumors. In:International histological classification of tumors, no 3. Geneva, World Health Organization.Google Scholar
  394. Fisher ER, Vuzevski VD (1968) Cytogenesis of schwannoma (neurilemoma), neurofibroma, and dermatosarcoma as revealed by electron microscopy. Am J Clin Pathol 49:141–154.PubMedGoogle Scholar
  395. Fisher ER, Wechsler H (1962) Granular cell myoblastoma — a misnomer. Cancer 15:936–954.PubMedCrossRefGoogle Scholar
  396. Fu Y-S, Gabbiani G, Kaye GJ, Lattes R (1975) Malignant soft tissue tumors of probable histiocytic origin (malignant fibrous histiocytomas):general considerations and electron microscopic and tissue culture studies. Cancer 35:176–198.PubMedCrossRefGoogle Scholar
  397. Gardner DL (1965) Pathology of the connective tissue diseases. Arnold, London.Google Scholar
  398. Ghosh BC, Ghosh L, Huvos AG, Fortner JG (1973) Malignant schwannoma. Cancer 31:184–190.PubMedCrossRefGoogle Scholar
  399. Hackney VC (1972) Nerve, fibrous, muscular and adipose tumors. In:Graham JH, Johnson WC, Helwig EB (eds) Dermal Pathology. Harper and Row, Hagerstown, pp 645–663.Google Scholar
  400. Hegler C, Wohlwill F (1930) Fettgewebsnekrosen in Subcutis und Knochenmark durch ein Carcinom des Pankreasschwanzes. Virchows Arch 274:784–802.CrossRefGoogle Scholar
  401. Holtz F (1959) Liposarcomas. Cancer 11:1103–1109.CrossRefGoogle Scholar
  402. Hosoi K (1931) Arch Surg 22:258. Zit nach Wachstein und Wolf (1944).CrossRefGoogle Scholar
  403. Inglis K (1958) Malignant tumours of the connective tissue. In:Raven RW (ed) Cancer, vol 2. Pathology of malignant tumours. Butterworth, London, pp 350–372.Google Scholar
  404. Jackson SH, Savidge RS, Stein L, Varley H (1952) Carcinoma of the pancreas associated with fat-necroses. Lancet II:962–967.CrossRefGoogle Scholar
  405. Keil W (1948) Multiple rezidivierende Lipome mit lokaler sarkomatöser Entartung. Virchows Arch 315:207–217.PubMedCrossRefGoogle Scholar
  406. Kempsen RL, Kyriakos M (1972) Fibroxanthosarcoma of the soft tissue. Cancer 29:961–976.CrossRefGoogle Scholar
  407. Knoth W, Bettge S (1958) Über besondere Veränderungen der Hautgefäße bei lymphatischer und myeloischer Leukämie. Dermatol Wochenschr 137:561–569.PubMedGoogle Scholar
  408. Lever WF (1967) Histopathology of the skin, 4th edn. Pitman, London.Google Scholar
  409. Lin JJ, Lin F (1974) Two entities in angiolipoma. Cancer 34:720–727.PubMedCrossRefGoogle Scholar
  410. Novy FG, Wilson JW (1956) Hibernomas, brown fat tumors. Arch Dermatol 73:149–157.CrossRefGoogle Scholar
  411. Ozzello L, Hamels J (1976) The histiocytic nature of dermatofibrosarcoma protuberans. Am J Clin Pathol 65:136–148.PubMedGoogle Scholar
  412. Ozzello L, Stout AP, Murray M (1963) Ultrastructural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16:331–344.PubMedCrossRefGoogle Scholar
  413. Pack GT, Pierson JC (1954) Liposarcoma. Surgery 36:687–712.PubMedGoogle Scholar
  414. Rosai J, Sumner HW, Kostianovsky M, Perez-Mesa C (1976) Angiosarcoma of the skin. Hum Pathol 7:83–109.PubMedCrossRefGoogle Scholar
  415. Seemayer TA, Knaak J, Wang NS, Ahmed MN (1975) On the ultrastructure of hibernoma. Cancer 36:1785–1793.PubMedCrossRefGoogle Scholar
  416. Sternberg SS (1952) Liposarcoma arising within a subcutaneous lipoma. Cancer 5:975–978.PubMedCrossRefGoogle Scholar
  417. Stout AP (1953) Tumors of the soft tissue. In:Atlas of tumor pathology, Sect II, Fascicle 5. Armed Forces Institute of Pathology, Washington DC.Google Scholar
  418. Stout AP, Hill WT (1958) Leiomyosarcoma of the superficial soft tissue. Cancer 11:744–754.CrossRefGoogle Scholar
  419. Taylor LM, Beahrs OH, Fontana RS (1961) Benign symmetric lipomatosis. Proc Mayo Clin 36:96–100.Google Scholar
  420. Tedeschi CG (1965) Pathological anatomy of adipose tissue. In:Renold AE, Cahill GF (eds) Adipose tissue. Handbook of Physiology. American Physiological Society, Washington Section 5, pp 141–168.Google Scholar
  421. Titone M (1936) Über ungewöhnlich ausgebreitete Fettgewebs-und Gewebsnekrosen bei Pankreaskrebs. Virchows Arch 297:416–424.CrossRefGoogle Scholar
  422. Trubowitz S, Sims CF (1962) Subcutaneous fat in leukemia and lymphoma. Arch Dermatol 86:520–524.PubMedCrossRefGoogle Scholar
  423. Undeutsch W (1957) Zum Problem der malignen Entartung der Neurofibromatosis Recklinghausen. Dermatol Wochenschr 136:1145–1153.PubMedGoogle Scholar
  424. Wachstein M, Wolf E (1944) General neurofibromatosis (von Recklinghausen disease) with local sarcomatous change and metastasis to lymph nodes. Arch Pathol 37:331–333.Google Scholar
  425. Wright CJE (1948) Liposarcoma arising in a simple lipoma. J Pathol 60:483–487.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • S. Marghescu
  • H. Kather
  • B. Simon
  • W. Mohr

There are no affiliations available

Personalised recommendations